Healthcare - Biotechnology - NASDAQ - GB
$ 3.53
-7.59 %
$ 591 M
Market Cap
-11.77
P/E
Price Target
Average
105.38%
Revenue Forecast
Estimate
69.00%
EBIT
Estimate
--5.54%
Net Income
Estimate
14.71%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Mereo BioPharma Group plc
Wall Street analysts predict an average 1-year price target for MREO of $7.25 , with forecasts ranging from a low of $6 to a high of $8 .
MREO Lowest Price Target
Wall Street Target
6 USD
69.97%
MREO Average Price Target
Wall Street Target
7.25 USD
105.38%
MREO Highest Price Target
Wall Street Target
8 USD
126.63%
REVENUE FORECAST
Revenue Forecast Chart MREO
EBIT FORECAST
EBIT Forecast Chart MREO
NET INCOME FORECAST
Net Income Chart MREO